Exoden All In One

Silicon Dioxide, Tetrasodium Pyrophosphate, Sodium Monofluorophosphate, Sodium Fluoride

Lifeon Corp.
Human Otc Drug
NDC 70602-010

Exoden All In One also known as Silicon Dioxide, Tetrasodium Pyrophosphate, Sodium Monofluorophosphate, Sodium Fluoride is a human otc drug labeled by 'Lifeon Corp.'. National Drug Code (NDC) number for Exoden All In One is 70602-010. This drug is available in dosage form of Paste. The names of the active, medicinal ingredients in Exoden All In One drug includes Silicon Dioxide - 10 g/100g Sodium Fluoride - .11 g/100g Sodium Monofluorophosphate - .38 g/100g Sodium Pyrophosphate - 3.4 g/100g . The currest status of Exoden All In One drug is Active.

Drug Information:

Drug NDC:	70602-010
The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
Proprietary Name:	Exoden All In One
Also known as the trade name. It is the name of the product chosen by the labeler.
Product Type:	Human Otc Drug
Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing.
Non Proprietary Name:	Silicon Dioxide, Tetrasodium Pyrophosphate, Sodium Monofluorophosphate, Sodium Fluoride
Also known as the generic name, this is usually the active ingredient(s) of the product.
Labeler Name:	Lifeon Corp.
Name of Company corresponding to the labeler code segment of the ProductNDC.
Dosage Form:	Paste
The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources.
Status:	Active
FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved.
Substance Name:	SILICON DIOXIDE - 10 g/100g SODIUM FLUORIDE - .11 g/100g SODIUM MONOFLUOROPHOSPHATE - .38 g/100g SODIUM PYROPHOSPHATE - 3.4 g/100g
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.
Route Details:	TOPICAL
The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Marketing Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.

Marketing Category:	UNAPPROVED DRUG OTHER
Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
Marketing Start Date:	13 Jul, 2022
This is the date that the labeler indicates was the start of its marketing of the drug product.
Marketing End Date:	08 May, 2026
This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
Listing Expiration Date:	31 Dec, 2023
This is the date when the listing record will expire if not updated or certified by the firm.

OpenFDA Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.

Manufacturer Name:	LIFEON Corp.
Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC.
Original Packager:	Yes
Whether or not the drug has been repackaged for distribution.
UNII:	ETJ7Z6XBU4 8ZYQ1474W7 C810JCZ56Q O352864B8Z
Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information.

Packaging Information:

Package NDC	Description	Marketing Start Date	Marketing End Date	Sample Available
70602-010-02	1 TUBE in 1 CARTON (70602-010-02) / 100 g in 1 TUBE (70602-010-01)	13 Jul, 2022	N/A	No
Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together.

Other medicines with the same generic name

Exoden All In One

Silicon Dioxide & more..

Paste
LIFEON Corp.
NDC: 70602-010

Purpose:

Anti plaque anti tartar anti cavity

Product Elements:

Exoden all in one silicon dioxide, tetrasodium pyrophosphate, sodium monofluorophosphate, sodium fluoride bentonite sorbitol glycerin stevioside xylitol carboxymethylcellulose sodium, unspecified sodium cocoyl glutamate green tea leaf rosemary glycyrrhiza glabra sage ginger eucalyptus oil menthol, unspecified form peppermint oil chamaecyparis obtusa wood oil water sodium pyrophosphate pyrophosphoric acid silicon dioxide silicon dioxide sodium monofluorophosphate fluoride ion sodium fluoride fluoride ion

Indications and Usage:

Aids in cleanness of teeth and protection of gum health

Warnings:

Ask a dentist before use if you have â¢ bleeding or redness lasting more than 2 weeks â¢ pain, swelling, pus, loose teeth, or more spacing between teeth these may be signs of periodontitis, a serious form of gum disease

Dosage and Administration:

Supervise children as necessary until capable of using without supervision adults and children 6 years of age and older: brush teeth thoroughly, preferably after each meal or at least twice a day, or as directed by a dentist or a physician children under 12 years: instruct in good brushing and rinsing habits (to minimize swallowing) children under 6 years: do not use unless directed by a dentist or a physician

Package Label Principal Display Panel:

Image description

Comments/ Reviews:

* Data of this site is collected from www.fda.gov. This page is for informational purposes only. Always consult your physician with any questions you may have regarding a medical condition.